CDC Greenlights Two Updated COVID-19 Vaccines, but How Will They Fare Against The Latest Variants? 5 Questions Answered
Author: Prakash Nagarkatti .; Mitzi Nagarkatti.
Source: Volume 24, Number 04, Fall 2023 , pp.99-100(2)
< previous article |next article > |return to table of contents
Abstract:
On Sept. 12, 2023, the Centers for Disease Control and Prevention recommended the newly formulated COVID-19 vaccines for all Americans ages 6 months and up, hours after its expert advisory committee voted 13 to 1 in favor of recommending the vaccines. The CDC’s broad recommendation comes one day after the Food and Drug Administration approved Moderna’s and Pfizer’s updated mRNA vaccines that target a previously dominant variant of the omicron family called XBB.1.5. The updated shots will be available to the public within days. Prakash Nagarkatti and Mitzi Nagarkatti, a husband and wife team of immunologists from the University of South Carolina, weigh in on how the new vaccines might stand up against the latest COVID-19 variants that are swirling across the globe.Keywords: Moderna’s and Pfizer’s updated mRNA vaccines
Affiliations:
1: University of South Carolina; 2: University of South Carolina.